Severe pertussis in infants: Estimated impact of first vaccine dose at 6 versus 8 weeks in Australia
We estimated the potential benefits of advancing the first dose of pertussis vaccine for infants from 8 to 6 weeks of age, using Australian national disease databases. Infants had notification rates 3-fold greater than the general population and accounted for 52% of recorded hospitalizations. Infants 1 and 2 months of age had notification rates 3.5 times (95% CI: 2.7-4.5) higher than infants 3 to 11 months of age. Estimation of acceleration of the vaccine to 6 weeks of age reduced average...[Show more]
|Collections||ANU Research Publications|
|Source:||The Pediatric Infectious Disease Journal|
|01_Foxwell_Severe_pertussis_in_infants:_2011.pdf||738.8 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.